The β-AR-induced cardiac hypertrophy has been reported to be suppressed by the knockdown of Epac1 [57] and inhibition of Epac1 activity using AM-001, a thieno [2,3-b]pyridine derivative, identified as a specific Epac1 inhibitor [58]. This evidence concerns the gene RAPGEF3 and cardiac hypertrophy.